This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Stephen James Simko
Introduction
Stephen James Simko is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments for various diseases. His work is characterized by a focus on bispecific antibodies, which have the potential to revolutionize therapeutic approaches.
Latest Patents
Stephen holds a patent titled "Dosing for Treatment with Anti-CD20/Anti-CD3 Bispecific Antibodies and Anti-CD79B Antibody Drug Conjugates." This patent reflects his commitment to advancing medical science and improving patient outcomes. He has 1 patent to his name, showcasing his innovative contributions to the industry.
Career Highlights
Stephen is currently employed at Genentech, Inc., a leading biotechnology company known for its cutting-edge research and development. His role at Genentech allows him to collaborate with some of the brightest minds in the field, further enhancing his impact on medical advancements.
Collaborations
Throughout his career, Stephen has worked alongside talented colleagues, including Klara Totpal and Michael C Wei. These collaborations have fostered a dynamic environment for innovation and have contributed to the success of his projects.
Conclusion
Stephen James Simko exemplifies the spirit of innovation in the biotechnology sector. His work on bispecific antibodies and his patent contributions highlight his dedication to improving healthcare solutions. His ongoing efforts at Genentech continue to inspire advancements in medical treatments.